nach oben

Erschienen in:

01.04.2000 | Questions and Answers

Questions and Answers

Erschienen in: Drugs | Sonderheft 2/2000

Einloggen, um Zugang zu erhalten

Excerpt

Question: Once initiated, antihypertensive drug therapy is usually lifelong, and there are clear clinical advantages to strategies that improve compliance, for example, once-daily therapy using a drug with a low adverse effect profile. Is there any evidence that increasing compliance reduces healthcare costs for patients with hypertension? …

Gosse P, Dubourg O, Gueret P, et al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5mg versus enalapril 20mg: results of LIVE study [abstract]. J Am Coll Cardiol 1999; 33 Suppl. A: 246

Titel: Questions and Answers
Publikationsdatum: 01.04.2000
Verlag: Springer International Publishing
Erschienen in: Drugs / Ausgabe Sonderheft 2/2000
Print ISSN: 0012-6667
Elektronische ISSN: 1179-1950
DOI: https://doi.org/10.2165/00003495-200059002-00005

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 2/2000

Clinical Positioning of Indapamide Sustained Release 1.5mg in Management Protocols for Hypertension

Pathoaetiology, Epidemiology and Diagnosis of Hypertension

Pharmacoeconomic Considerations in the Management of Hypertension

Diuretics as a Basis of Antihypertensive Therapy